201. [Effect of mast cell activation on microcirculation of intestinal mucosa in inflamed small intestine of the rat].
- Author
-
Ruh J, Schmidt E, Gebhard MM, Klar E, Glaser F, and Herfarth C
- Subjects
- Animals, Blood Flow Velocity drug effects, Blood Flow Velocity physiology, Crohn Disease chemically induced, Disease Models, Animal, Histamine H1 Antagonists pharmacology, Histamine Release drug effects, Indomethacin, Ketotifen pharmacology, Male, Mast Cells drug effects, Microcirculation drug effects, Microcirculation physiopathology, Microscopy, Fluorescence, Rats, Rats, Sprague-Dawley, Regional Blood Flow drug effects, Regional Blood Flow physiology, Crohn Disease physiopathology, Histamine Release physiology, Intestinal Mucosa blood supply, Intestine, Small blood supply, Mast Cells physiology
- Abstract
Intravital microscopy and FITC-labeled erythrocytes were used to investigate villous perfusion in the rat small intestine in a model of inflammatory bowel disease. Inflammation was induced with s.c. application of Indomethacin. It has previously been demonstrated that systemic Indomethacin leads to an increase in villous blood flow in the small intestine of the rat. In order to determine whether mast cell activation may contribute to the increase in villous perfusion, Ketotifen was used to inhibit mast cell degranulation. We found that Ketotifen significantly reduced villous perfusion in the inflamed intestine, but had no effect in the control group. We conclude that mast cell activation is one of the mechanisms leading to hyperemia in the mucosa of the small intestine in this animal model. Further studies are required to determine whether mast cell stabilizers may be beneficial in the treatment of inflammatory bowel disease in man.
- Published
- 1998